The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional

Wentao Zhang1,2, Ning Duan2, Qian Zhang3

  • 1Department of Orthopedics, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710005, Shaanxi, China.

Insights

Carboxyl-terminal binding protein 2 (CtBP2) is overexpressed in atrophic nonunion, hindering bone healing. Lower NADH levels disrupt CtBP2 binding to p300-Runx2, blocking bone-related gene expression.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Orthopedics

Background:

  • Atrophic nonunion is a complex fracture healing failure with unclear molecular mechanisms.
  • Carboxyl-terminal binding proteins (CtBPs) are NADH-sensitive transcriptional corepressors implicated in various diseases.

Purpose of the Study:

  • To investigate the role of CtBP2 in the molecular pathology of atrophic nonunion.
  • To elucidate the mechanism by which CtBP2 influences bone-related gene expression in nonunion.

Main Methods:

  • Mass spectrometry to identify protein complexes involving CtBP2.
  • Analysis of CtBP2 and NADH levels in atrophic nonunion tissues.
  • Investigating the effect of NADH levels on gene expression in vitro.

Main Results:

  • CtBP2, not CtBP1, is significantly overexpressed in atrophic nonunion tissues.
  • CtBP2 forms a complex with p300 and Runx2.
  • Reduced NADH levels in nonunion disrupt CtBP2 dimerization, impairing p300-Runx2 access to bone-related gene promoters (e.g., OSC, ALPL, COL1A1).
  • Restoring NADH levels with CoCl2 reversed the downregulation of these genes.

Conclusions:

  • CtBP2 acts as a NADH-dependent repressor of the p300-Runx2 transcriptional complex.
  • NADH levels critically regulate CtBP2 binding to p300-Runx2, thereby controlling the expression of genes essential for bone formation and development.
  • This mechanism provides new insights into atrophic nonunion pathogenesis and potential therapeutic targets.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Master Transcription Regulators02:23

Master Transcription Regulators

2.8K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.3K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

2.6K
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
694
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K